Hjem › Neuroblastom › Florida › Gainesville
Kliniske studier for Neuroblastom i Gainesville, FL
6 studier for Neuroblastom søker deltakere på steder i og rundt Gainesville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- University of Florida, Gainesville
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- University of Florida, Gainesville
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- University of Florida, Gainesville
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RekruttererFase 1/2
- University of Florida, Gainesville
Neuroblastom-studier i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Gainesville
- Hjertesvikt13 studier
- Brystkreft12 studier
- Type 1-diabetes12 studier
- Parkinsons sykdom12 studier
- Ikke-småcellet lungekreft10 studier
- Kolorektal kreft9 studier
- Lungekreft9 studier
- Kreft (alle typer)9 studier
- Kardiovaskulær sykdom9 studier
- Prostatakreft8 studier
- Lette kognitive vansker8 studier
- Akut myelogen leukemi8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.